{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -0.06911008, "regularMarketPrice": 14.46, "marketState": "REGULAR", "exchange": "NMS", "shortName": "BELLUS Health Inc.", "longName": "BELLUS Health Inc.", "messageBoardId": "finmb_102942", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1063891800000, "fiftyTwoWeekLowChange": 8.08, "fiftyTwoWeekLowChangePercent": 1.2664577, "fiftyTwoWeekRange": "6.38 - 14.54", "fiftyTwoWeekHighChange": -0.07999992, "fiftyTwoWeekHighChangePercent": -0.005502058, "fiftyTwoWeekLow": 6.38, "fiftyTwoWeekHigh": 14.54, "dividendDate": 1566172800, "earningsTimestamp": 1683921660, "earningsTimestampStart": 1691492340, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.66, "epsForward": -0.92, "epsCurrentYear": -0.85, "priceEpsCurrentYear": -17.011765, "sharesOutstanding": 126684000, "bookValue": 3.089, "fiftyDayAverage": 10.1848, "fiftyDayAverageChange": 4.2752, "fiftyDayAverageChangePercent": 0.41976276, "twoHundredDayAverage": 9.62345, "twoHundredDayAverageChange": 4.8365498, "twoHundredDayAverageChangePercent": 0.50257957, "marketCap": 1833383424, "forwardPE": -15.717391, "priceToBook": 4.6811266, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.7 - Hold", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -0.010000229, "regularMarketTime": 1684261822, "regularMarketDayHigh": 14.475, "regularMarketDayRange": "14.31 - 14.475", "regularMarketDayLow": 14.31, "regularMarketVolume": 3375018, "regularMarketPreviousClose": 14.47, "bid": 14.46, "ask": 14.47, "bidSize": 8, "askSize": 29, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 14.33, "averageDailyVolume3Month": 4427478, "averageDailyVolume10Day": 1905430, "displayName": "BELLUS Health", "symbol": "BLU"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "275 Armand-Frappier Boulevard", "city": "Laval", "state": "QC", "zip": "H7V 4A7", "country": "Canada", "phone": "450 680 4500", "fax": "450 680 4501", "website": "https://www.bellushealth.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada.", "fullTimeEmployees": 74, "companyOfficers": [{"maxAge": 1, "name": "Mr. Roberto Francesco Bellini", "age": 42, "title": "Pres, CEO & Director", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 790350, "fmt": "790.35k", "longFmt": "790,350"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ramzi  Benamar", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 650478, "fmt": "650.48k", "longFmt": "650,478"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Andreas  Orfanos FFPM, M.B.B.Ch, MBA", "age": 63, "title": "Chief Operating Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 417577, "fmt": "417.58k", "longFmt": "417,577"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Denis  Garceau Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 496564, "fmt": "496.56k", "longFmt": "496,564"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Catherine M. Bonuccelli M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 741662, "fmt": "741.66k", "longFmt": "741,662"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel  Matthews", "title": "Director of Investor Relations & Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tony  Matzouranis", "age": 49, "title": "Chief Bus. Officer", "yearBorn": 1973, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sebastien  Roy", "age": 46, "title": "Corp. Sec.", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 6, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}